DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Microfluidic Cell-based Assays in Stem Cell and Other Rare Cell Type Research

Abstract

Microfluidics is a technology defined by the engineered precise manipulation of minute amount of liquids through channels with dimensions in the micron scale. Much of microfluidic devices used for biomedical purposes are produced in the form of so called “lab-on-a-chip” format, where multiple steps of conventional biochemical analyses such as staining, washing, and signal collection are miniaturized and integrated into chips fabricated from polymer or glass. Cell-based microfluidic lab-on-achip technology provides some obvious advantages: 1) drastically reduced sample and reagent requirement, and 2) separation and detection with improved sensitivity due to fluid properties at the microscale, i.e. laminar flow. Based on these two advantages, the obvious place where microfluidic cell assays will provide the most benefit is wherescientists must gather much information from precious little sample. Stem cells and other precious cell types such as circulating tumor cells (CTCs), and rare immune subsets are the perfect match for microfluidic multiplex assays. The recent demonstration that multiple cellular changes such as surface receptor activation, protein translocation, long and short RNA, and DNA changes can all be extracted from intact single cells paves the way to systems level understanding of cellular states during development or disease. Finally, with the ability to preservemore » cell integrity in a microfluidic device during multiplexed analysis, one also preserves the single cell resolution, where information regarding the cell-to-cell heterogeneity during differentiation or response to stimuli is vitally important.« less

Authors:
 [1]
  1. Sandia National Lab. (SNL-NM), Albuquerque, NM (United States). Dept. of Biotechnology and Bioengineering
Publication Date:
Research Org.:
Sandia National Lab. (SNL-CA), Livermore, CA (United States)
Sponsoring Org.:
USDOE National Nuclear Security Administration (NNSA)
OSTI Identifier:
1427263
Report Number(s):
SAND-2015-1659J
Journal ID: ISSN 9999-0015; 579718
Grant/Contract Number:  
AC04-94AL85000
Resource Type:
Accepted Manuscript
Journal Name:
Archives of Stem Cell Research
Additional Journal Information:
Journal Volume: 2; Journal Issue: 1; Journal ID: ISSN 9999-0015
Publisher:
SciMed Central
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Wu, Meiye. Microfluidic Cell-based Assays in Stem Cell and Other Rare Cell Type Research. United States: N. p., 2015. Web.
Wu, Meiye. Microfluidic Cell-based Assays in Stem Cell and Other Rare Cell Type Research. United States.
Wu, Meiye. Mon . "Microfluidic Cell-based Assays in Stem Cell and Other Rare Cell Type Research". United States. https://www.osti.gov/servlets/purl/1427263.
@article{osti_1427263,
title = {Microfluidic Cell-based Assays in Stem Cell and Other Rare Cell Type Research},
author = {Wu, Meiye},
abstractNote = {Microfluidics is a technology defined by the engineered precise manipulation of minute amount of liquids through channels with dimensions in the micron scale. Much of microfluidic devices used for biomedical purposes are produced in the form of so called “lab-on-a-chip” format, where multiple steps of conventional biochemical analyses such as staining, washing, and signal collection are miniaturized and integrated into chips fabricated from polymer or glass. Cell-based microfluidic lab-on-achip technology provides some obvious advantages: 1) drastically reduced sample and reagent requirement, and 2) separation and detection with improved sensitivity due to fluid properties at the microscale, i.e. laminar flow. Based on these two advantages, the obvious place where microfluidic cell assays will provide the most benefit is wherescientists must gather much information from precious little sample. Stem cells and other precious cell types such as circulating tumor cells (CTCs), and rare immune subsets are the perfect match for microfluidic multiplex assays. The recent demonstration that multiple cellular changes such as surface receptor activation, protein translocation, long and short RNA, and DNA changes can all be extracted from intact single cells paves the way to systems level understanding of cellular states during development or disease. Finally, with the ability to preserve cell integrity in a microfluidic device during multiplexed analysis, one also preserves the single cell resolution, where information regarding the cell-to-cell heterogeneity during differentiation or response to stimuli is vitally important.},
doi = {},
journal = {Archives of Stem Cell Research},
number = 1,
volume = 2,
place = {United States},
year = {Mon Mar 23 00:00:00 EDT 2015},
month = {Mon Mar 23 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
The DOI is not currently available

Save / Share: